Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gus A Baker

Showing results (91-100 of 98) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 98 results.
Healthcare (Basel, Switzerland)|July 2, 2021
European Clinical Neuropsychology: Role in Healthcare and Access to Neuropsychological ServicesErich Kasten, Fernando Barbosa, Mary H Kosmidis, et al.
Epilepsy & Behavior : E&B|January 21, 2019
Fetal antiepileptic drug exposure and learning and memory functioning at 6 years of age: The NEAD prospective observational studyMorris J Cohen, Kimford J Meador, Ryan May, et al.
Lancet (London, England)|April 11, 2021
The SANAD II study of the effectiveness and cost-effectiveness of levetiracetam, zonisamide, or lamotrigine for newly diagnosed focal epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trialAnthony Marson, Girvan Burnside, Richard Appleton, et al.
Lancet (London, England)|April 11, 2021
The SANAD II study of the effectiveness and cost-effectiveness of valproate versus levetiracetam for newly diagnosed generalised and unclassifiable epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trialAnthony Marson, Girvan Burnside, Richard Appleton, et al.
Epilepsia Open|April 15, 2026
The Global Epilepsy Needs Study (GENS): A mixed-methods, multi-country exploration of the unmet psychosocial and everyday needs of people with epilepsyGus A Baker, Sandeep Kumar Bagga, Donna Walsh, et al.
Lancet (London, England)|March 27, 2007
The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trialAnthony G Marson, Asya M Al-Kharusi, Muna Alwaidh, et al.
Lancet (London, England)|March 27, 2007
The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trialAnthony G Marson, Asya M Al-Kharusi, Muna Alwaidh, et al.
The Lancet. Global Health|March 14, 2024
National plans and awareness campaigns as priorities for achieving global brain healthSebastian F Winter, Donna Walsh, Coriene Catsman-Berrevoets, et al.
Pageof 10

Showing results (91-100 of 98) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 98 results.
Healthcare (Basel, Switzerland)|July 2, 2021
European Clinical Neuropsychology: Role in Healthcare and Access to Neuropsychological ServicesErich Kasten, Fernando Barbosa, Mary H Kosmidis, et al.
Epilepsy & Behavior : E&B|January 21, 2019
Fetal antiepileptic drug exposure and learning and memory functioning at 6 years of age: The NEAD prospective observational studyMorris J Cohen, Kimford J Meador, Ryan May, et al.
Lancet (London, England)|April 11, 2021
The SANAD II study of the effectiveness and cost-effectiveness of levetiracetam, zonisamide, or lamotrigine for newly diagnosed focal epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trialAnthony Marson, Girvan Burnside, Richard Appleton, et al.
Lancet (London, England)|April 11, 2021
The SANAD II study of the effectiveness and cost-effectiveness of valproate versus levetiracetam for newly diagnosed generalised and unclassifiable epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trialAnthony Marson, Girvan Burnside, Richard Appleton, et al.
Epilepsia Open|April 15, 2026
The Global Epilepsy Needs Study (GENS): A mixed-methods, multi-country exploration of the unmet psychosocial and everyday needs of people with epilepsyGus A Baker, Sandeep Kumar Bagga, Donna Walsh, et al.
Lancet (London, England)|March 27, 2007
The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trialAnthony G Marson, Asya M Al-Kharusi, Muna Alwaidh, et al.
Lancet (London, England)|March 27, 2007
The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trialAnthony G Marson, Asya M Al-Kharusi, Muna Alwaidh, et al.
The Lancet. Global Health|March 14, 2024
National plans and awareness campaigns as priorities for achieving global brain healthSebastian F Winter, Donna Walsh, Coriene Catsman-Berrevoets, et al.
Pageof 10